GFAP and neoplasm: Although not statistically significant, the lowest median survival time was found for patients with a GFAP-negative tumor in the study cohort (6.8 years for GFAP-negative tumors vs 8.9 in the low-density group), but this was not observed in the in-cohort validation (4.1 vs 4.8 years).